Brandon Capital, a biosciences venture capital firm based in Australia has reached the first close of its sixth fund at $180 million.

The fund will invest in life sciences startups in Australia and New Zealand, with a specific interest in scale-ups. The firm also plans to use the fund to expand its investment presence in the United Kingdom, Europe, and the